Services
  • Custom Research & Development
    • Nucleic Acid
      • siRNA In Vitro Screening Service
      • One-Stop Antisense Oligonucleotide (ASO) Development
      • circRNA
    • Viral Vector
      • Adeno-associated Virus Vector
      • Adenoviral Vector Development Service
      • Lentiviral Vector Development Service
      • Herpes Simplex Virus Vector Development Service
      • Vaccinia Viral Vector Development Service
      • Baculovirus Vector
      • Other Viral Vectors
  • Custom Production
    • Custom Viral Vector Production
    • Nucleic Acid
      • PMO Synthesis
      • PPMO Synthesis
      • Custom Oligonucleotide Modification
  • Custom Formulation & Conjugation
    • Lipid Nanoparticle (LNP) Conjugation Service
      • Mitochondrial Targeting LNP
    • Antibody-siRNA Conjugates (ARCs) Synthesis
    • Antibody-Oligo Conjugates Synthesis Services
    • N-Acetylgalactosamine (GalNAc)
    • Others
      • Development of Polyplexes as Gene Delivery System
      • Development of Dendrimers as Gene Delivery System
      • Development of Stem Cells as Gene Delivery System
      • Development of Dendritic Cell as Gene Delivery System
      • Development of Bacteria as Gene Delivery System
      • Custom Aptamer Screening
      • Custom Nanoparticles Service
      • Custom Polymers Service
      • Custom Nucleic Acid Nanostructure Service
      • Custom Exosomes Service
  • GTOnco™ Immuno-Oncology Assay Services
    • GTOnco™ I-O Assays for In Vitro Study
    • GTOnco™ I-O Assays for In Vivo Study
  • Analytical Testing & Quality Control
    • Nucleic Acid Anaylsis
      • Identity of Nucleic Acid
      • Concentration of Nucleic Acid
      • Safety of Nucleic Acid
      • Potency of Nucleic Acid
      • Purity of Nucleic Acid
    • Viral Vector Analysis Service
      • Identity of Viral Vector
      • Titer of Viral Vector
      • Safety of Viral Vector
      • Potency of Viral Vector
      • Purity of Viral Vector
    • Other Service
      • Mitochondrial Toxicity Assay
      • RNA Profiling Service
  • CRISPR assisted Gene Editing Solutions
    • CRISPR assisted Cell Line Development
      • Gene Knockout
      • Gene Knock-in
      • Point Mutation
      • Cas9 Overexpressing Cell Line Development
      • dCas9-VPH Overexpressing Cell Line Development
      • dCas9-VPR Overexpressing Cell Line Development
      • dCas9-KRAB Overexpressing Cell Line Development
    • CRISPR related Delivery Agent Construction
      • Lipid Nanoparticle (LNP) Formulation through CRISPR
      • Viral Vector Construction through CRISPR
      • gRNA Cloning through CRISPR
      • Gene Editing Donor Vector Construction through CRISPR
    • CRISPR based Screening Solutions
      • Genome-Wide CRISPR Screening
      • CRISPRa Screening
      • CRISPRi Screening
      • Single-Cell CRISPR Screening
      • Custom CRISPR Screening
    • Disease Modeling related Gene Editing
    • Library Design through CRISPR
    • Nuclease Activity Measurement
Products
  • Antisense Oligonucleotides (ASOs)
    • Cancer
    • Cytomegalovirus Retinitis
    • Familial Hypercholesterolemia
    • Viral Hemorrhagic Fever
    • HIV/AIDS
    • Spinal Muscular Atrophy
    • Duchenne Muscular Dystrophy
    • Hypertriglyceridemia
    • ASO Others
  • Recombinant Virus
    • Recombinant Adeno-Associated Virus
    • Recombinant Adenovirus
    • Recombinant Lentivirus
    • Recombinant Retrovirus
  • SARS-CoV-2 Research
    • Pseudovirus
    • Overexpressing Virus
  • Small Interfering RNA (siRNA)
  • Circular RNAs (circRNAs) Products
    • Reporter Circular RNA Products
Platforms
  • Phosphorodiamidate Morpholino Oligomer Development
  • GTOnco™ Platform for Gene Therapy-based I-O Drug Development
  • NeuroST™ - Expert for Neuroscience Drug Discovery
    • iPSC Ex Vivo Modeling
    • Organoid Ex Vivo Modeling
    • Neurodegenerative Disease related Drug Discovery
    • Microelectrode Array
    • Patch Clamp
    • High-Content Screening
    • iPSC Generation
    • iPSC Characterization
    • iPSC Expansion & Banking
    • Gene Editing
    • Custom iPSC Differentiation
    • Custom Disease Modeling
Therapeutic Areas
  • Gene Therapy Development for Diseases
    • Gene Therapy Development for Genetic Disorders
    • Gene Therapy Development for Acquired Diseases
Resources
  • Support Knowledge
    • Cell Therapy VS Gene Therapy
    • Viral Vectors for Gene Therapy
    • Therapeutic Nucleic Acids
    • Approaches to Genome Editing
    • Strategies for Gene Delivery
    • Gene Therapy in Clinical Trials
    • Genes and Associated Diseases
    • Gene Therapy for Human Genetic Disorders
    • Strategies for Circular RNA Synthesis
  • Podcasts
  • Webinars
    • Programmable Molecular Tools for Biology and Genome Editing
    • Development of Gene Therapy for Genetic Hearing Loss
    • Optimal Therapeutic Intervention Timepoints for siRNA-Based Huntington's Disease Therapies
Company
  • About Us
  • Careers
  • Contact Us
  • Inquiry
Hot Products:
Dx Receptor PAR4 ACE BCR-exon 1/ABL-exon 2 ERalpha HPV-18 K-ras DMD-exon 8 DNMT FV-AS ICAM-1 LMNA-exon 11 Ras p53 ADC COL1A1 CagA/flaA/flaB/vacA GPR75 HBV IL-15
Creative Biolabs-Gene Therapy
  • Home
  • Products
  • Recombinant Virus
  • Recombinant Adeno-Associated Virus
  • AAV8-U6 (MCS)-CAG (mCherry), RNAi(CAT#: AAV-GTK0303WQ)

AAV8-U6 (MCS)-CAG (mCherry), RNAi(CAT#: AAV-GTK0303WQ)

Datasheet

The product Cat#AAV-GTK0303WQ is adeno-associated virus vector. It is suitable for stable overexpression of exogenous gene in various types of cells and can be used in gene therapy and RNAi research.

Specifications
Family Parvoviridae
Species Adeno-associated virus (AAV)
Serotype AAV8
Tropism Both nondividing and dividing cells
Titer >1.00E+12 v.g./mL
Reporter mCherry
Application RNAi

Related Products

shRNA Adeno-associated Virus Serotype 2, pU6-(N4bp2l2-shRNA-Seq1) (CAT#:AAV-SI1916WQ) Recombinant adeno-associated virus type 2, pU6-(Human FSIP1), Overexpression (CAT#:AAV-GTOH0057WQ) shRNA Adeno-associated Virus Serotype 2, pH1-(BC027231-shRNA-Seq6) (CAT#:AAV-SI2838WQ) shRNA Adeno-associated Virus Serotype 2, pH1-(Prr13-shRNA-Seq1) (CAT#:AAV-SI3163WQ) shRNA Adeno-associated Virus Serotype 2, p7SK-(FAM53C-shRNA-Seq2) (CAT#:AAV-SI3222WQ) Recombinant adeno-associated virus type 2, pU6-(Mouse Eya1), Overexpression (CAT#:AAV-GTOH0681WQ) shRNA Adeno-associated Virus Serotype 2, pU6-(VARS2-shRNA-Seq2) (CAT#:AAV-SI1534WQ) shRNA Adeno-associated Virus Serotype 2, pH1-(CAMSAP1-shRNA-Seq3) (CAT#:AAV-SI0805WQ)

    Products

    • Antisense Oligonucleotides (ASOs)
      • Cancer
      • Cytomegalovirus Retinitis
      • Familial Hypercholesterolemia
      • Viral Hemorrhagic Fever
      • HIV/AIDS
      • Spinal Muscular Atrophy
      • Duchenne Muscular Dystrophy
      • Hypertriglyceridemia
      • ASO Others
    • Recombinant Virus
      • Recombinant Adeno-Associated Virus
      • Recombinant Adenovirus
      • Recombinant Lentivirus
      • Recombinant Retrovirus
    • SARS-CoV-2 Research
      • Pseudovirus
      • Overexpressing Virus
    • Small Interfering RNA (siRNA)
    • Circular RNAs (circRNAs) Products
      • Reporter Circular RNA Products

Online Inquiry

For research use only. Not intended for any clinical use.
  • <
    >
    Sun Mon Tue Wed Thu Fri Sat
    -

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Services
  • Custom Nucleic Acid Production
  • Custom GalNAc-siRNA conjugation
  • Custom Viral Vector Development
  • siRNA In Vitro Screening
  • GTOnco™ Immuno-Oncology Assay Services
Products
  • Recombinant Virus
  • Antisense Oligonucleotides (ASOs)
  • Small Interfering RNA (siRNA)
  • SARS-CoV-2 Research
Contact Us
  • Tel:
  • Fax:
  • Global Locations
Enter your email here to subscribe.
Submit
    • Follow Us:
ISO 9001 Certified - Creative Biolabs Quality Management System.
Copyright © 2025 Creative Biolabs. All Rights Reserved.